Erste Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,800
| Closed | -$947K | – | 967 |
|
|
2023
Q1 | $947K | Hold |
8,800
| – | – | 0.02% | 369 |
|
|
2022
Q4 | $968K | Hold |
8,800
| – | – | 0.02% | 360 |
|
|
2022
Q3 | $506K | Hold |
8,800
| – | – | 0.01% | 423 |
|
|
2022
Q2 | $245K | Hold |
8,800
| – | – | 0.01% | 497 |
|
|
2022
Q1 | $330K | Buy |
+8,800
| New | +$330K | 0.01% | 472 |
|